NDAQ Nasdaq
- 61.980
- -0.250-0.40%
Nasdaq News
Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. From The Nasdaq Stock Market
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended on March 18,
Argus raised Nasdaq price target to $66
Gronghui, May 15 | Argus Research: Raised NASDAQ's target price from $64 to $66, maintaining a “buy” rating.
Press Release: Nasdaq Announces 2024 Annual Meeting of Shareholders
Nasdaq Announces 2024 Annual Meeting of Shareholders NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2024 Annual Meeting of Shareholders for June 11, 2024, at
Nasdaq Is Maintained at Buy by Argus Research
Nasdaq Is Maintained at Buy by Argus Research
Nasdaq Price Target Raised to $66.00/Share From $64.00 by Argus Research
Nasdaq Price Target Raised to $66.00/Share From $64.00 by Argus Research
Argus Adjusts Price Target on Nasdaq to $66 From $64
Nasdaq (NDAQ) has an average outperform rating and a price target range of $50 to $80, according to analysts polled by Capital IQ. Price: 61.35, Change: +0.73, Percent Change: +1.21
Nasdaq Announces 2024 Annual Meeting of Shareholders
PDF Version NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2024 Annual Meeting of Shareholders for June 11, 2024, at 8:00 AM ET. The virtual meeting we
Full Video Coverage: Three CFOs on IPOs Panel From IPO Edge Bootcamp at Nasdaq
Full Video Coverage: Investor Engagement in Private Vs. Public Markets Panel From IPO Edge Bootcamp at Nasdaq
Sector Update: Financial
Financial stocks were easing in Monday afternoon trading, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) both off 0.2% recently. The Philadelphia Housing Index was shedd
Update: Market Chatter: Nasdaq Considering Sale of Solovis Business
(Updates with additional details in the second and third paragraphs, Nasdaq declines to comment in the fourth paragraph.) Nasdaq (NDAQ) is considering a sale of its Solovis business as part of an effo
Nasdaq Weighs Sale of Solovis Unit in Wake of Adenza Acquisition - Report
Nasdaq Said To Weigh Sale Of Solovis Amid Streamlining Effort
Nasdaq Said To Weigh Sale Of Solovis Amid Streamlining Effort
Intel Rises in Premarket on Report of $11 Billion Apollo Investment in New Chip Plant
By Steve Gelsi Apollo is front-runner on deal after it outshines KKR and Stonepeak, the WSJ report says Intel Corp's stock rose 1.1% in premarket trading on Monday after The Wall Street Journal repo
Why Investors Shouldn't Be Surprised By Nasdaq, Inc.'s (NASDAQ:NDAQ) P/E
With a price-to-earnings (or "P/E") ratio of 35x Nasdaq, Inc. (NASDAQ:NDAQ) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 17x and even P/E's lower than 9x are not unusual.
Readiness and the Road to IPO Panel From IPO Edge Bootcamp at Nasdaq
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2024
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2024, short interest in 3,072 Nasdaq Global MarketSM securities totaled 11,683,381,571 shares compared with
Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Piper Sandl
Nasdaq Cut to Neutral From Buy by Rosenblatt
Nasdaq Cut to Neutral From Buy by Rosenblatt
Nasdaq Price Target Cut to $64.00/Share From $76.00 by Rosenblatt
Nasdaq Price Target Cut to $64.00/Share From $76.00 by Rosenblatt
Analysis
Price Target
No Data
